Latest news
FDA Approves Garzulys as Third Biosimilar to NovoLog - Drug TopicsDrug Topics · Mon, 03 Aug 2026 14:02:46 GMTMeitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection - BioSpaceBioSpace · Fri, 31 Jul 2026 02:43:16 GMTFDA Approves Meitheal’s Garzulys™, Biosimilar to Novo Nordisk’s NovoLog® (Insulin Aspart) - Pearce IPPearce IP · Thu, 30 Jul 2026 07:00:00 GMTNovolog Ltd. Number of Employees 2026 | Employee Count & Headcount Data - Revelio LabsRevelio Labs · Wed, 29 Jul 2026 23:59:18 GMT